Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-12-29
2008-09-30
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S008100, C514S012200, C530S409000
Reexamination Certificate
active
07429567
ABSTRACT:
The present invention is directed to a therapeutic composition in which human PDGF is bound directly to peptides that self assemble into a biologically compatible gel. When implanted in a patient's body, the composition provides for the slow, sustained release of PDGF. The composition will be especially useful in treating patients who have undergone a myocardial infarction.
REFERENCES:
patent: 5670483 (1997-09-01), Zhang et al.
patent: 5955343 (1999-09-01), Holmes et al.
patent: 6086866 (2000-07-01), Kouri
patent: 6548630 (2003-04-01), Zhang et al.
patent: 2002/0160471 (2002-10-01), Kisiday et al.
patent: 2003/0139333 (2003-07-01), Pawliuk et al.
patent: 2004/0105839 (2004-06-01), Park
patent: 2004/0253679 (2004-12-01), Epstein et al.
patent: WO 03/096972 (2003-11-01), None
patent: WO 2004/045531A 2 (2004-06-01), None
Hsieh et al. Controlled Delivery of PDGF-BB, an Endothelial-Derived Cardiomyocyte Survival Factor . . . Circulation. Oct. 25, 2006, vol. 112, No. 17, Supplement II, pp. II-J and II-K.
Clarke, et al., “Transformation of NIH 3T3 Cells by a Humanc-siscDNA Clone,”Nature 308:464 (1984).
Gazit, et al., “Expression of the Normal HumansislPDGF-2 Coding Sequence Induces Cellular Transformation,”Cell 39:89 (1984).
Davis, et al., “Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells,”Circulation 111:442-450 (2005).
Smits, et al., “Expression of Platelet-Derived Growth Factor and Its Receptors in Proliferative Disorders of Fibroblastic Origin,”Am. J. Pathol. 140:639 (1992).
Ferns, et al., “Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF,”Science 253:1129-1132 (1991).
Rutherford et al., “Substantial Inhibition of Neo-Intimal Response to Ballon Injury in the Rat Carotid Artery Using a Combination of Antibodies to Platelet-Derived Growth Factor-BB and Basic Fibroblast Growth Factor,”Atherosclerosis 130:45-51 (1997).
Jawien et al., “Platelet-Derived Growth Factor Promotes Smooth Muscle Migration and Intimal Thickening in a Rat Model of Ballon Angioplasty,”J. Clin. Invest. 89:507-511 (1992).
Deuel, et al., “Chemotaxis of Monocytes and Neutrophils to Platelet-Derived Growth Factor,”J. Clin. Invest. 69:1046-1049 (1981).
Siegbhan, et al., “Differential Effects of the Various Isoforms of Platelet-Derived Growth Factor on Chemotaxis of Fibroblasts, Monocytes, and Granulocytes,”J. Clin. Invest. 85:916-920 (1990).
Smits, et al., “Neurotropic Activity of Platelet-Derived Growth Factor (PDGF): Rat Neuronal Cells Possess Functional PDGF β-Type Receptors and Respond to PDGF,”Proc. Natl. Acad. Sci. USA. 88:8159-8163 (1991).
Yeh, et al., “PDGF: A-Chain Gene is Expressed by Mammalian Neurons During Development and in Maturity,”Cell 64:209-216 (1991).
Robson, et al., “Platelet-Derived Growth Factor BB for the Treatment of Chronic Pressure Ulcers,”Lancet 339:23-25 (1992).
Narmoneva, et al., “Endothelial Cells Promote Cardiac Myocyte Survival and Spatial Reorganization: Implications for Cardiac Regeneration,”Circulation 110:962-968 (2004).
Kuramochi, et al., “Cardiac Endothelial Cells Regulate Reactive Oxygen Species-Induced Cardiomyocyte Apoptosis Through Neuregulin-1β/erbB4 Signaling,”J. Biol. Chem. 279:51141-51147 (2004).
International Search Report for PCT/US05/46768.
“Written Opinion of the International Searching Authority for PCT/US05/46768”.
Hsieh Patrick
Lee Richard T.
Law Office of Michael A. Sanzo, LLC
Russel Jeffrey E
Sanzo Michael A.
The Brigham and Women's Hospital, Inc.
LandOfFree
Sustained delivery of PDGF using self-assembling peptide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained delivery of PDGF using self-assembling peptide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained delivery of PDGF using self-assembling peptide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3985035